Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 29, 2019Science Translational MedicineOpen Access

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMichael K. LoCenters for Disease Control and PreventionFFFriederike FeldmannNational Institutes of HealthJGJoy GaryFox Chase Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lo et al. (2019) studied this question.

synapsesocial.com/papers/69ff8debef8139f8ff7763f7https://doi.org/10.1126/scitranslmed.aau9242
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outbreak Investigation of Nipah Virus Disease in Kerala, India, 20182018 · 345 citations
  2. 2Relapsed and late‐onset Nipah encephalitis2002 · 308 citations
  3. 3Late Ebola virus relapse causing meningoencephalitis: a case report2016 · 363 citations
  4. 4Effective Chemical Inactivation of Ebola Virus2016 · 109 citations
  5. 5Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody2014 · 198 citations